83 related articles for article (PubMed ID: 24939421)
1. Vimocin and vidapin, cyclic KTS peptides, are dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity.
Momic T; Katzehendler J; Benny O; Lahiani A; Cohen G; Noy E; Senderowitz H; Eble JA; Marcinkiewicz C; Lazarovici P
J Pharmacol Exp Ther; 2014 Sep; 350(3):506-19. PubMed ID: 24939421
[TBL] [Abstract][Full Text] [Related]
2. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin.
Hunter EJ; Hamaia SW; Gullberg D; Malcor JD; Farndale RW
Toxicol Appl Pharmacol; 2021 Oct; 428():115669. PubMed ID: 34363821
[TBL] [Abstract][Full Text] [Related]
5. Effect of VP12 and viperistatin on inhibition of collagen-receptor-dependent melanoma metastasis.
Staniszewska I; Walsh EM; Rothman VL; Gaathon A; Tuszynski GP; Calvete JJ; Lazarovici P; Marcinkiewicz C
Cancer Biol Ther; 2009 Aug; 8(15):1507-16. PubMed ID: 19502781
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of the selectivity of KTS-disintegrins for the alpha1beta1 integrin.
Kisiel DG; Calvete JJ; Katzhendler J; Fertala A; Lazarovici P; Marcinkiewicz C
FEBS Lett; 2004 Nov; 577(3):478-82. PubMed ID: 15556632
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin.
Brown MC; Eble JA; Calvete JJ; Marcinkiewicz C
Biochem J; 2009 Jan; 417(1):95-101. PubMed ID: 18774946
[TBL] [Abstract][Full Text] [Related]
8. KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin.
Calvete JJ; Marcinkiewicz C; Sanz L
Curr Pharm Des; 2007; 13(28):2853-9. PubMed ID: 17979730
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma.
Bazan-Socha S; Bukiej A; Pulka G; Marcinkiewicz C; Musial J
Clin Exp Allergy; 2006 Sep; 36(9):1184-91. PubMed ID: 16961719
[TBL] [Abstract][Full Text] [Related]
10. Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth.
Brown MC; Staniszewska I; Del Valle L; Tuszynski GP; Marcinkiewicz C
Int J Cancer; 2008 Nov; 123(9):2195-203. PubMed ID: 18712720
[TBL] [Abstract][Full Text] [Related]
11. The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.
Ghazaryan N; Movsisyan N; Macedo JC; Vaz S; Ayvazyan N; Pardo L; Logarinho E
Invest New Drugs; 2019 Oct; 37(5):1044-1051. PubMed ID: 30680583
[TBL] [Abstract][Full Text] [Related]
12. Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.
Momic T; Cohen G; Reich R; Arlinghaus FT; Eble JA; Marcinkiewicz C; Lazarovici P
Toxins (Basel); 2012 Oct; 4(10):862-77. PubMed ID: 23162702
[TBL] [Abstract][Full Text] [Related]
13. Role of Integrins α1β1 and α2β1 in Wound and Tumor Angiogenesis in Mice.
Ghatak S; Niland S; Schulz JN; Wang F; Eble JA; Leitges M; Mauch C; Krieg T; Zigrino P; Eckes B
Am J Pathol; 2016 Nov; 186(11):3011-3027. PubMed ID: 27639165
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha2beta1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein.
Sabherwal Y; Rothman VL; Dimitrov S; L'Heureux DZ; Marcinkiewicz C; Sharma M; Tuszynski GP
Exp Cell Res; 2006 Aug; 312(13):2443-53. PubMed ID: 16762342
[TBL] [Abstract][Full Text] [Related]
15. Blocking of α1β1 and α2β1 adhesion molecules inhibits eosinophil migration through human lung microvascular endothelial cell monolayer.
Bazan-Socha S; Żuk J; Plutecka H; Jakieła B; Mlicka-Kowalczyk E; Krzyżanowski B; Marcinkiewicz C; Zaręba L; Bazan JG; Musiał J
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1444-51. PubMed ID: 25531708
[TBL] [Abstract][Full Text] [Related]
16. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between integrins alpha1beta1 and alpha2beta1 in renal epithelial cells.
Abair TD; Sundaramoorthy M; Chen D; Heino J; Ivaska J; Hudson BG; Sanders CR; Pozzi A; Zent R
Exp Cell Res; 2008 Nov; 314(19):3593-604. PubMed ID: 18809396
[TBL] [Abstract][Full Text] [Related]
18. Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer.
Grzesiak JJ; Bouvet M
Pancreas; 2007 Mar; 34(2):220-8. PubMed ID: 17312461
[TBL] [Abstract][Full Text] [Related]
19. Targeting α1 inserted domain (I) of α1β1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis.
Morjen M; Othman H; Abdelkafi-Koubaa Z; Messadi E; Jebali J; El Ayeb M; Abid NS; Luis J; Marrakchi N
Int J Biol Macromol; 2018 Oct; 117():790-799. PubMed ID: 29870815
[TBL] [Abstract][Full Text] [Related]
20. Identification of α2β1 integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae.
Arlinghaus FT; Momic T; Ammar NA; Shai E; Spectre G; Varon D; Marcinkiewicz C; Heide H; Lazarovici P; Eble JA
Toxicon; 2013 Mar; 64():96-105. PubMed ID: 23319078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
